CME Group Inc (NASDAQ: CME) has a higher price-to-earnings ratio of 27.71x compared to its average ratio. CME has 36-month beta value of 0.45. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 3 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for CME is 359.28M, and currently, short sellers hold a 1.58% ratio of that float. The average trading volume of CME on July 09, 2025 was 2.50M shares.
CME) stock’s latest price update
CME Group Inc (NASDAQ: CME)’s stock price has decreased by -2.45% compared to its previous closing price of $282.55. seekingalpha.com reported 2025-07-07 that CME Group gets rated buy again, reaffirming my last rating. The firm is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key peers, and cashflow growth. Two key business segments of operating exchanges, as well as providing market data to subscribers, have seen demand growth.
CME’s Market Performance
CME Group Inc (CME) has experienced a 0.00% fall in stock performance for the past week, with a 0.27% rise in the past month, and a 8.32% rise in the past quarter. The volatility ratio for the week is 2.21%, and the volatility levels for the past 30 days are at 1.91% for CME. The simple moving average for the last 20 days is 1.07% for CME stock, with a simple moving average of 11.75% for the last 200 days.
Analysts’ Opinion of CME
Many brokerage firms have already submitted their reports for CME stocks, with Morgan Stanley repeating the rating for CME by listing it as a “Overweight.” The predicted price for CME in the upcoming period, according to Morgan Stanley is $301 based on the research report published on April 08, 2025 of the current year 2025.
Raymond James, on the other hand, stated in their research note that they expect to see CME reach a price target of $287. The rating they have provided for CME stocks is “Outperform” according to the report published on March 10th, 2025.
Citigroup gave a rating of “Neutral” to CME, setting the target price at $250 in the report published on January 06th of the current year.
CME Trading at -0.25% from the 50-Day Moving Average
After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.21% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CME starting from SHEPARD WILLIAM R, who purchase 256 shares at the price of $270.53 back on Jun 25 ’25. After this action, SHEPARD WILLIAM R now owns 258,196 shares of CME Group Inc, valued at $69,282 using the latest closing price.
SHEPARD WILLIAM R, the Director of CME Group Inc, purchase 11 shares at $270.53 during a trade that took place back on Jun 25 ’25, which means that SHEPARD WILLIAM R is holding 2,455 shares at $3,054 based on the most recent closing price.
Stock Fundamentals for CME
Current profitability levels for the company are sitting at:
- 0.65 for the present operating margin
- 0.86 for the gross margin
The net margin for CME Group Inc stands at 0.58. The total capital return value is set at 0.11. Equity return is now at value 13.40, with 2.50 for asset returns.
Based on CME Group Inc (CME), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 1.14. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 25.08.
Currently, EBITDA for the company is 4.61 billion with net debt to EBITDA at 0.4. When we switch over and look at the enterprise to sales, we see a ratio of 16.13. The receivables turnover for the company is 8.16for trailing twelve months and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.02.
Conclusion
To put it simply, CME Group Inc (CME) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
